Glibenez-Retard

Country of origin: France
Pharm-Group: Antidiabetic agents - sulfonylurea derivatives

Manufacturers: Pfizer (France)
International name: Glipizide
Synonyms: Antidiab, Glibenez, Glinez, Glucotrol HL, Minidiab
Dosage forms: 5mg film-coated tablets, 10mg film-coated tablets, 10mg film-coated controlled-release tablets, 5mg film-coated controlled-release tablets
Composition: Active substance - Glipizide.

Indications for use:

1. Diabetes mellitus type 2 in the absence of the effect of a low-calorie diet, adequate physical activity, etc.
2. Diabetic microangiopathy

Contraindications:

1. Hypersensitivity
2. Diabetic ketoacidosis
3. Diabetic coma
4. Juvenile diabetes mellitus type 1
5. Fever
6. Injuries
7. Surgical interventions
8. Pregnancy
9. Lactation

Side effect:
For slow-acting glipizide:

1. From the nervous system and sensory organs: dizziness, headache, insomnia, drowsiness, anxiety, depression, confusion, gait disturbance, paresthesia, hyperesthesia, blurred vision, eye pain, conjunctivitis, retinal hemorrhage.
2. From the cardiovascular system and blood: syncope, arrhythmia, arterial hypertension, feeling of hot flashes.
3. Metabolism: hypoglycemia.
4. From the gastrointestinal tract: anorexia, nausea, vomiting, feeling of heaviness in the epigastric region, dyspepsia, constipation, blood in the stool.
5. From the skin: rash, urticaria, itching.
6. From the respiratory system: rhinitis, pharyngitis, dyspnea.
7. From the genitourinary system: dysuria, decreased libido.
8. Other: thirst, trembling, peripheral edema, non-localized pain throughout the body, arthralgia